Cargando…

Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease

OBJECTIVE: Similar white matter hyperintensities (WMH) might have different impact on the cognitive outcomes in patients with cerebral small vessel disease (CSVD). This study is to assess the possible factors related to the heterogeneity of WMH in cognitively impaired patients with CVSD. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tingting, Jin, Aoming, Fu, Ying, Zhang, Zaiqiang, Li, Shaowu, Wang, David, Wang, Yilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695488/
https://www.ncbi.nlm.nih.gov/pubmed/34956241
http://dx.doi.org/10.3389/fimmu.2021.803504
_version_ 1784619589740527616
author Wang, Tingting
Jin, Aoming
Fu, Ying
Zhang, Zaiqiang
Li, Shaowu
Wang, David
Wang, Yilong
author_facet Wang, Tingting
Jin, Aoming
Fu, Ying
Zhang, Zaiqiang
Li, Shaowu
Wang, David
Wang, Yilong
author_sort Wang, Tingting
collection PubMed
description OBJECTIVE: Similar white matter hyperintensities (WMH) might have different impact on the cognitive outcomes in patients with cerebral small vessel disease (CSVD). This study is to assess the possible factors related to the heterogeneity of WMH in cognitively impaired patients with CVSD. METHODS: We analyzed data from a cohort of patients with CVSD who were recruited consecutively from the Beijing Tiantan Hospital from 2015 to 2020. WMH, lacunes, enlarged perivascular space (ePVS), microbleeds and lacunar infarcts were rated on brain MRI. A score of <26 on the Montreal Cognitive Assessment (MoCA) indicated cognitive impairment. A mismatch was defined as the severity of WMH not matching the severity of cognitive dysfunction. Type-1 mismatch was defined as a mild WMH (Fazekas score = 0-1) associated with cognitive impairment, and type-2 mismatch was defined as a severe WMH (Fazekas score = 5-6) associated with normal cognitive function. Ultrasmall superparamagnetic iron oxide (USPIO)-enhanced SWI on 3-Tesla MRI was used to image the penetrating arteries in basal ganglia to explore the underlying mechanism of this mismatch. Multivariable logistic regression was used to analyze the association between the imaging features and cognitive impairment. RESULTS: In 156 patients, 118 (75.6%) had cognitive impairment and 37 (23.7%) showed mismatch. Twenty five (16.0%) had type-1 mismatch and 12 (7.7%) had type-2 mismatch. Regression analysis found that WMH, lacunes, microbleeds and total CSVD scores were associated with cognitive impairment and were independent of vascular risk factors. However, lacunes, microbleeds and total CSVD scores were related to the mismatch between WMH and cognitive impairment (p=0.006, 0.005 and 0.0001, respectively). Specially, age and ePVS in basal ganglia were related to type-1 mismatch (p=0.04 and 0.02, respectively); microbleeds and total CSVD scores were related to type-2 mismatch (p=0.01 and 0.03, respectively). Although the severity of WMH was similar, the injury scores of penetrating arteries were significantly different between those with and without cognitive impairment (p=0.04). CONCLUSIONS: Heterogeneity of WMH was present in cognitively impaired patients with CSVD. Conventional imaging features and injury of penetrating arteries may account for such heterogeneity, which can be a hallmark for early identification and prevention of cognitive impairment.
format Online
Article
Text
id pubmed-8695488
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86954882021-12-24 Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease Wang, Tingting Jin, Aoming Fu, Ying Zhang, Zaiqiang Li, Shaowu Wang, David Wang, Yilong Front Immunol Immunology OBJECTIVE: Similar white matter hyperintensities (WMH) might have different impact on the cognitive outcomes in patients with cerebral small vessel disease (CSVD). This study is to assess the possible factors related to the heterogeneity of WMH in cognitively impaired patients with CVSD. METHODS: We analyzed data from a cohort of patients with CVSD who were recruited consecutively from the Beijing Tiantan Hospital from 2015 to 2020. WMH, lacunes, enlarged perivascular space (ePVS), microbleeds and lacunar infarcts were rated on brain MRI. A score of <26 on the Montreal Cognitive Assessment (MoCA) indicated cognitive impairment. A mismatch was defined as the severity of WMH not matching the severity of cognitive dysfunction. Type-1 mismatch was defined as a mild WMH (Fazekas score = 0-1) associated with cognitive impairment, and type-2 mismatch was defined as a severe WMH (Fazekas score = 5-6) associated with normal cognitive function. Ultrasmall superparamagnetic iron oxide (USPIO)-enhanced SWI on 3-Tesla MRI was used to image the penetrating arteries in basal ganglia to explore the underlying mechanism of this mismatch. Multivariable logistic regression was used to analyze the association between the imaging features and cognitive impairment. RESULTS: In 156 patients, 118 (75.6%) had cognitive impairment and 37 (23.7%) showed mismatch. Twenty five (16.0%) had type-1 mismatch and 12 (7.7%) had type-2 mismatch. Regression analysis found that WMH, lacunes, microbleeds and total CSVD scores were associated with cognitive impairment and were independent of vascular risk factors. However, lacunes, microbleeds and total CSVD scores were related to the mismatch between WMH and cognitive impairment (p=0.006, 0.005 and 0.0001, respectively). Specially, age and ePVS in basal ganglia were related to type-1 mismatch (p=0.04 and 0.02, respectively); microbleeds and total CSVD scores were related to type-2 mismatch (p=0.01 and 0.03, respectively). Although the severity of WMH was similar, the injury scores of penetrating arteries were significantly different between those with and without cognitive impairment (p=0.04). CONCLUSIONS: Heterogeneity of WMH was present in cognitively impaired patients with CSVD. Conventional imaging features and injury of penetrating arteries may account for such heterogeneity, which can be a hallmark for early identification and prevention of cognitive impairment. Frontiers Media S.A. 2021-12-09 /pmc/articles/PMC8695488/ /pubmed/34956241 http://dx.doi.org/10.3389/fimmu.2021.803504 Text en Copyright © 2021 Wang, Jin, Fu, Zhang, Li, Wang and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wang, Tingting
Jin, Aoming
Fu, Ying
Zhang, Zaiqiang
Li, Shaowu
Wang, David
Wang, Yilong
Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease
title Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease
title_full Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease
title_fullStr Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease
title_full_unstemmed Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease
title_short Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease
title_sort heterogeneity of white matter hyperintensities in cognitively impaired patients with cerebral small vessel disease
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695488/
https://www.ncbi.nlm.nih.gov/pubmed/34956241
http://dx.doi.org/10.3389/fimmu.2021.803504
work_keys_str_mv AT wangtingting heterogeneityofwhitematterhyperintensitiesincognitivelyimpairedpatientswithcerebralsmallvesseldisease
AT jinaoming heterogeneityofwhitematterhyperintensitiesincognitivelyimpairedpatientswithcerebralsmallvesseldisease
AT fuying heterogeneityofwhitematterhyperintensitiesincognitivelyimpairedpatientswithcerebralsmallvesseldisease
AT zhangzaiqiang heterogeneityofwhitematterhyperintensitiesincognitivelyimpairedpatientswithcerebralsmallvesseldisease
AT lishaowu heterogeneityofwhitematterhyperintensitiesincognitivelyimpairedpatientswithcerebralsmallvesseldisease
AT wangdavid heterogeneityofwhitematterhyperintensitiesincognitivelyimpairedpatientswithcerebralsmallvesseldisease
AT wangyilong heterogeneityofwhitematterhyperintensitiesincognitivelyimpairedpatientswithcerebralsmallvesseldisease